Literature DB >> 10874742

The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.

G Dougan1, M Ghaem-Maghami, D Pickard, G Frankel, G Douce, S Clare, S Dunstan, C Simmons.   

Abstract

Mammals have evolved a sophisticated immune system for handling antigens encountered at their mucosal surfaces. The way in which mucosally delivered antigens are handled influences our ability to design effective mucosal vaccines. Live attenuated derivatives of pathogens are one route towards the development of mucosal vaccines. However, some molecules, described as mucosal immunogens, are inherently immunogenic at mucosal surfaces. Studies on mucosal immunogens may facilitate the identification of common characteristics that contribute to mucosal immunogenicity and aid the development of novel, non-living mucosal vaccines and immunostimulators.

Mesh:

Substances:

Year:  2000        PMID: 10874742      PMCID: PMC1692779          DOI: 10.1098/rstb.2000.0610

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  43 in total

1.  Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.

Authors:  R Lagos; A Fasano; S S Wasserman; V Prado; O San Martin; P Abrego; G A Losonsky; S Alegria; M M Levine
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

2.  Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves.

Authors:  R M Tsolis; L G Adams; T A Ficht; A J Bäumler
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements.

Authors:  G Frankel; A D Phillips; I Rosenshine; G Dougan; J B Kaper; S Knutton
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

4.  A common mucosal immunologic system involving the bronchus, breast and bowel.

Authors:  J Bienenstock; M McDermott; D Befus; M O'Neill
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

5.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Role of bacterial intimin in colonic hyperplasia and inflammation.

Authors:  L M Higgins; G Frankel; I Connerton; N S Gonçalves; G Dougan; T T MacDonald
Journal:  Science       Date:  1999-07-23       Impact factor: 47.728

7.  Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.

Authors:  T S Coster; C W Hoge; L L VanDeVerg; A B Hartman; E V Oaks; M M Venkatesan; D Cohen; G Robin; A Fontaine-Thompson; P J Sansonetti; T L Hale
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.

Authors:  L C Agren; L Ekman; B Löwenadler; J G Nedrud; N Y Lycke
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

9.  Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia.

Authors:  M Bajaj-Elliott; R Poulsom; S L Pender; N C Wathen; T T MacDonald
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 10.  Importance of receptor binding in the immunogenicity, adjuvanticity and therapeutic properties of cholera toxin and Escherichia coli heat-labile enterotoxin.

Authors:  T O Nashar; N A Williams; T R Hirst
Journal:  Med Microbiol Immunol       Date:  1998-06       Impact factor: 3.402

View more
  3 in total

Review 1.  Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.

Authors:  Aman Kumar; Melissa Ellermann; Vanessa Sperandio
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

2.  Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.

Authors:  Cristiano G Moreira; Regan Russell; Animesh Anand Mishra; Sanjeev Narayanan; Jennifer M Ritchie; Matthew K Waldor; Meredith M Curtis; Sebastian E Winter; David Weinshenker; Vanessa Sperandio
Journal:  MBio       Date:  2016-06-07       Impact factor: 7.867

3.  Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice.

Authors:  Simon Clare; Victoria John; Alan W Walker; Jennifer L Hill; Cei Abreu-Goodger; Christine Hale; David Goulding; Trevor D Lawley; Pietro Mastroeni; Gadi Frankel; Anton J Enright; Elena Vigorito; Gordon Dougan
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.